Clinical trial
Prapela™ SVS: A Cost-effective Stochastic Vibro-tactile Stimulation Device to Improve the Clinical Course of Infants With Neonatal Opioid Withdrawal Syndrome.
NCT04834297 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prapela™ SVS: A Cost-effective Stochastic Vibro-tactile Stimulation Device to Improve the Clinical Course of Infants With Neonatal Opioid Withdrawal Syndrome.
- Lead sponsor
- Tufts Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 21, 2021
- Completion date
- June 10, 2025
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neonatal opioid withdrawal syndrome